Markets:

Overview

News

Currencies

International

Treasuries

Medipharm Labs Corp (OP:MEDIF)

0.0553 -0.0009 (-1.60%)

Streaming Delayed Price Updated: 9:50 AM EDT, Aug 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medipharm Labs Corp

< Previous 1 2 3 4 5 6 Next >

Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate

June 02, 2025

ISS concludes that Apollo “has not presented a compelling case for change”

From MediPharm Labs Corp.

Via GlobeNewswire

MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital

May 30, 2025

From Apollo Technology Capital Corporation

Via GlobeNewswire

MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder

May 29, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q2 2024 ↗

August 14, 2024

MediPharm Labs just reported results for the second quarter of 2024.

Via InvestorPlace

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q1 2024 ↗

May 15, 2024

MediPharm Labs just reported results for the first quarter of 2024.

Via InvestorPlace

Alleged Securities Fraud at MediPharm Labs Says Apollo Capital

May 29, 2025

From Apollo Technology Capital Corporation

Via GlobeNewswire

MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan

May 28, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma

May 27, 2025

From Apollo Technology Capital Corporation

Via GlobeNewswire

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q4 2023 ↗

March 27, 2024

MediPharm Labs just reported results for the fourth quarter of 2023.

Via InvestorPlace

MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement

May 26, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.

May 23, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting

May 23, 2025

From Apollo Technology Capital Corporation

Via GlobeNewswire

MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June

May 22, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings

May 21, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations ↗

April 04, 2025

This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.

Via Benzinga

Topics Government

CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth ↗

November 14, 2024

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024...

Via Benzinga

MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY ↗

August 14, 2024

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an...

Via Benzinga

Topics Cannabis

The Canadian Cannabis Report- Monday, Aug 12 ↗

August 13, 2024

The past, present and future of the Canadian cannabis sector.

Via Talk Markets

Topics Cannabis

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now ↗

August 09, 2024

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,...

Via Benzinga

Topics Cannabis

Executive Changes In Cannabis Industry You Should Know About, New Appointments & More ↗

July 03, 2024

Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as...

Via Benzinga

Topics Cannabis

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method ↗

June 20, 2024

Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to...

Via Benzinga

Topics Cannabis

Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position' ↗

May 15, 2024

Via Benzinga

The Canadian Cannabis Report - Monday, April 22 ↗

April 22, 2024

The past, present and future of the Canadian cannabis sector, based on the performanceof the MCCCI, which is a proprietary index of 14 stocks.

Via Talk Markets

Topics Cannabis

This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses ↗

March 27, 2024

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,...

Via Benzinga

The Canadian Cannabis Report - Monday, March 25 ↗

March 27, 2024

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 14 stocks

Via Talk Markets

Topics Cannabis

Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil ↗

February 07, 2024

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products...

Via Benzinga

Topics Cannabis

Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 ↗

December 22, 2023

This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and...

Via Benzinga

Topics Cannabis

MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report ↗

November 14, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of...

Via Benzinga

New Cannabis Products Energize Global Health & Wellness Market, Including Australia ↗

October 16, 2023

In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness solutions.

Via Benzinga

Topics Cannabis

MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M ↗

October 02, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.